Karat demanded action in the Human Papilloma Virus (HPV) vaccine trials which was allegedly conducted on thousands of children belonging to the ST, SC and economically poor households in Andhra Pradesh and Gujarat in 2010, so that a strong message goes out to other potential exploiters of India's poor through such irregular clinical trials.
In a letter to Union Health Minister Ghulam Nabi Azad, she also urged the government to pay a compensation of Rs ten lakh to each of those who were used in the trials.
In her letter, Brinda said "it is deeply regrettable that in spite of the assurances you made on the floor of the House ...You have not taken any action whatsoever against those responsible...In the light of the report of the Standing Committee, it would be legitimate to ask is it because the health interests of poor adivasi and dalit children have little value for you that you did not act?"
She further mentioned in her letter that individuals in institutions such as the Drugs Controller General of India, Indian Council of Medical research and the National Rural Health Mission working under his Ministry have in this case been shown to have allegedly manipulated and violated rules and regulations and acted to facilitate the interests of the two foreign pharma companies.
She also demanded action against the officials who misused the NHRM logo in Andhra Pradesh and a time-bound inquiry by an impartial agency into the process of granting marketing permission to the two pharma companies.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
